Immunotherapy with Keytruda (Pembolizumab) Doctors Abroad — Page 3

Associate Professor Ayse Irem Yasin is an ESMO-certified board oncologist who specialises in immunotherapy targets for solid tumours at Medipol Acibadem District Hospital.

• Holds a European Society for Medical Oncology (ESMO) Board Certificate from Paris
• Completed a specialised breast cancer unit residency at Maggiore della Carita Hospital in Italy
• Gained clinical experience at world-leading institutions including Harvard Medical School and Cleveland Clinic
• Expertise covers complex immunotherapy applications for lung, gastrointestinal, and gynaecological cancers

Professor Birol Baytan has performed 950 bone marrow transplants and leads one of Turkey's largest paediatric transplant units at Emsey Hospital.

• Specialises in managing complex solid tumours including neuroblastoma, brain tumours, and Ewing sarcoma
• Provides immunotherapy with Keytruda alongside advanced CAR T-cell therapy protocols
• Expert in identifying genetic changes in cancer cells through cytogenetic studies
• Published 15 articles in international medical journals on paediatric blood disorders
• Author of three medical books focused on childhood health and oncology

Professor Serdar Bedii Omay is a dual-qualified haematologist and oncologist who earned his PhD from Japan Mie Medical School. He specialises in treating resistant blood cancers at Emsey Hospital.

• Manages immunotherapy protocols for resistant Non-Hodgkin and Hodgkin lymphoma cases
• Expert in CAR T-cell therapy and molecular haematology research
• Published over 65 scientific articles in international medical journals
• Former Professor of Haematology at two leading Turkish universities
• Member of the bone marrow transplant unit featuring 45 high-intensity care beds

Associate Professor Nail Paksoy is a Board Certified medical oncologist who specialises in immunotherapy and advanced cancer clinical trials.

• ESMO Board Certified in Medical Oncology, recognised by the professional body for oncology in Europe
• Serves as a Sub-Investigator for multiple international clinical trials involving Pembrolizumab (Keytruda)
• Completed a specialised fellowship in Allergy and Immunology, providing deep insight into immune system responses
• Associate Professor at Medipol University, where he contributes to the next generation of cancer specialists

Prof. Dr. Gül Alço is a radiation oncologist with about 27 years of experience. She treats breast, lung, prostate, gastrointestinal, gynecologic, central nervous system, head and neck, soft tissue, and bone cancers with radiotherapy.

Her expertise includes adaptive radiotherapy and radiosurgery. She uses advanced radiation techniques to provide personalized, evidence-based care in a multidisciplinary, patient-centered setting.